HIV-positive women may experience menopause at a younger age than their HIV-negative counterparts, according to a study presented at the Fifth...

Once-daily Kaletra (lopinavir/ritonavir) dosing may be an option for treatment-experienced people living with HIV, according to study results...

Chronic stress may increase the risk of non-AIDS, age-related health problems in people living with HIV, according to a team of Spanish resear...

People whose virus is well controlled by a regimen containing Norvir (ritonavir)-boosted Reyataz (atazanavir) can drop the Norvir—while...

Switching to Norvir-boosted Prezista monotherapy after achieving an undetectable viral load using combination ARV treatment worked well

There were no HIV transmissions and few birth defects in the babies of HIV-positive African women who were treated with ARV therapy.

A quadruple combination of four similar drugs from the same class—Truvada (tenofovir plus emtricitabine), Retrovir (zidovudine) and Ziag...

A daily supplement including key vitamins and minerals showed promise for increasing survival in Ugandan children living with HIV, according t...

HIV-positive children exposed to single-dose Viramune (nevirapine) at birth are more likely to have virologic success later with a Kaletra (lo...

People on a regimen containing either once or twice daily Viramune (nevirapine) were as able as people on a Norvir (ritonavir)?boosted Reyataz...